Paragon 28, Inc. (NYSE:FNA) Major Shareholder Sells $2,142,278.64 in Stock

Paragon 28, Inc. (NYSE:FNA) major shareholder Mvm Partners, Llc sold 164,664 shares of the firm’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $13.01, for a total transaction of $2,142,278.64. Following the transaction, the insider now directly owns 8,854,883 shares in the company, valued at approximately $115,202,027.83. This trade represents a 1.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Mvm Partners, Llc also recently made the following trade(s):

• On Tuesday, March 4th, Mvm Partners, Llc sold 619,747 shares of Paragon 28 stock. The stock was sold at an average price of $12.99, for a total transaction of $8,050,513.53.
• On Monday, January 27th, Mvm Partners, Llc sold 27,142 shares of Paragon 28 stock. The stock was sold at an average price of $11.62, for a total transaction of $315,390.04.
• On Thursday, January 23rd, Mvm Partners, Llc sold 20,136 shares of Paragon 28 stock. The shares were sold at an average price of $11.63, for a total transaction of $234,181.68.

Paragon 28 Trading Down 0.0 %

Shares of Paragon 28 stock opened at $13.03 on Friday. The company has a debt-to-equity ratio of 0.79, a current ratio of 3.50 and a quick ratio of 1.60. The firm has a fifty day moving average price of $12.07 and a 200 day moving average price of $9.34. Paragon 28, Inc. has a 1 year low of $4.65 and a 1 year high of $13.13. The stock has a market cap of $1.09 billion, a PE ratio of -17.60 and a beta of 1.54.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Barclays PLC raised its position in shares of Paragon 28 by 180.6% in the third quarter. Barclays PLC now owns 84,812 shares of the company’s stock worth $567,000 after acquiring an additional 54,591 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Paragon 28 by 2,141.7% during the third quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock worth $5,243,000 after purchasing an additional 749,865 shares in the last quarter. GSA Capital Partners LLP purchased a new stake in Paragon 28 during the 3rd quarter valued at about $386,000. Ballentine Partners LLC grew its stake in Paragon 28 by 15.0% during the 4th quarter. Ballentine Partners LLC now owns 15,630 shares of the company’s stock valued at $161,000 after acquiring an additional 2,043 shares in the last quarter. Finally, State Street Corp grew its stake in shares of Paragon 28 by 2.6% in the 3rd quarter. State Street Corp now owns 1,563,331 shares of the company’s stock valued at $10,443,000 after buying an additional 39,075 shares during the period. Hedge funds and other institutional investors own 63.57% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on FNA. Canaccord Genuity Group set a $13.00 price objective on shares of Paragon 28 in a research note on Wednesday, January 29th. Needham & Company LLC restated a “hold” rating and issued a $13.00 target price on shares of Paragon 28 in a research note on Wednesday, January 29th. William Blair downgraded shares of Paragon 28 from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Finally, Stephens restated an “equal weight” rating and issued a $13.00 target price (down from $14.00) on shares of Paragon 28 in a research note on Thursday, January 30th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $14.20.

About Paragon 28

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.